NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.68% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 4.54% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 4.38% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.15% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.96% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.88% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.85% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 3.69% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.63% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.56% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.50% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.47% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 3.17% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.11% |
| HLUN-B | H Lundbeck A/S | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |